Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
6061	Just to keep things updated: AGPH holders are getting a better deal as WLA trad	billkirn	-	5/8/1999
6060	Note: WLA shares are trading in the lower conversion range. AGPH holders are	billkirn	-	5/6/1999
6059	Monday April 26 5:01 PM ET Study: Drugs Hiding, Not Curing HIV By MALCOLM RI	Oliver & Co	-	4/27/1999
6058	This is the second time that you've spammed the AGPH thread in violation of	scaram(o)uche	-	4/23/1999
6057	Agouron sending proxy now. Calculation of conversion starts April 29th ending	billkirn	-	4/23/1999
6056	Steve: If Wla keeps drifting down, the equivalent value will be somewhat below	billkirn	-	3/31/1999
6055	GSD.. Good Question. Must be the risk that Warner Lambert will go lower than th	billkirn	-	3/31/1999
6054	WLA Buyout Good chart. Go to agouron.com Click on "Important information	GSD	-	3/29/1999
6053	[PROC. AMER. ASSOC. CANCER RES. 40, March 1999] Copyright © 1999 by t	scaram(o)uche	-	3/26/1999
6052	[PROC. AMER. ASSOC. CANCER RES. 40, March 1999] Copyright © 1999 by t	scaram(o)uche	-	3/26/1999
6051	Hello Bill...hope all is well. Heard any updates on the status of the buyou	Steve Fancy	-	3/26/1999
6050	Morgan Stanley Cuts Agouron to Hold on Price Basis eom	John Romeo	-	3/5/1999
6049	Agouron overcomes hurdle to develop cancer drugs March 4, 1999 07:38 PM LA J	Jan P	-	3/5/1999
6048	dogmatic bunk. (eom)	scaram(o)uche	-	3/2/1999
6047	I found this on another Pharmex chat www.stockhouse.com, it is good.	David Birman	-	3/2/1999
6046	Here's a few: Alza (Crescendo), Biochem Pharma (Clinichem), Interneuron (I	John Metcalf	-	2/28/1999
6045	Hi Bill, I'm looking for a list of Biotech companies that have spun-off a p	Elmer	-	2/28/1999
6044	Thank you Steve for the analysis EOM	billkirn	-	2/20/1999
6043	Bill, although I'm now free of AGPH, and not 100% sure what you're s	Steve Fancy	-	2/20/1999
6042	I don't understand agph movement. The lower WLA goes the more valuable AGP	billkirn	-	2/12/1999
6041	AP is carrying a story on a new antiviral agent effective against HIV and HPV.	Henry Niman	-	2/11/1999
6040	J. Kernan's report was based in part on an extensive article in today's	Henry Niman	-	2/10/1999
6039	CNBC reports that BMY has notified Entremed that it will not continue funding t	Jan P	-	2/10/1999
6038	Today's WSJ has an extensive review on HIV resistance. Details linked to a	Henry Niman	-	2/5/1999
6037	Judy, Speaking of AGPH, LGND, and BioCognizance, VRTX came out with a press rel	Henry Niman	-	2/4/1999

Go to reply# or date (mm/dd/yy):